February Virtual HC Roundtable: Breaking Down Barriers Slowing Drug Development
The current paradigm of drug
development is unsustainable as costs and investors’ aversion to risk continues
to increase. Non-profit research foundations are emerging as the architect of
innovative collaborative models to overcome systemic obstacles and accelerate
the development of new therapeutic approaches.
Kathy Giusti, MBA 1985, is
Founder and CEO of the Multiple Myeloma Research Foundation (MMRF), which has
completely transformed the treatment landscape for this uncommon and fatal
cancer and is lauded as a model for other diseases to emulate. She will
share her unique business model, review some of the challenges she has
overcome, and share her approach to the latest obstacle – building open access
data platforms to speed drug discovery and development.
Date: Tuesday, February 12, 2013
Time: 12:00 noon - 1:00 pm ET
Location: Virtual. Dial-in information will be sent 24-hours prior to the call.
Cost: FREE for members; $50 non-members
For a complete
listing of Virtual HC Roundtables, including past recordings and presentations,
please click here.